BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25196525)

  • 1. Recent approaches in vaccine development against Streptococcus pneumoniae.
    Tarahomjoo S
    J Mol Microbiol Biotechnol; 2014; 24(4):215-27. PubMed ID: 25196525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and perspectives on protein-based pneumococcal vaccines.
    Darrieux M; Goulart C; Briles D; Leite LC
    Crit Rev Microbiol; 2015 Jun; 41(2):190-200. PubMed ID: 23895377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.
    Pichichero ME
    Expert Rev Vaccines; 2017 Dec; 16(12):1181-1190. PubMed ID: 29130395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumococcal vaccine: protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine].
    Pletz MW
    Med Monatsschr Pharm; 2011 Jun; 34(6):201-5. PubMed ID: 21812250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine.
    Jwa MY; Jeong S; Ko EB; Kim AR; Kim HY; Kim SK; Seo HS; Yun CH; Han SH
    J Microbiol; 2018 Aug; 56(8):579-585. PubMed ID: 30047087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal vaccination in adults: does it really work?
    Pitsiou GG; Kioumis IP
    Respir Med; 2011 Dec; 105(12):1776-83. PubMed ID: 21816596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin.
    Guo M; Guo X; Zhang C; Zhu S; Zhang Y; Gu T; Kong W; Wu Y
    Infect Immun; 2022 Jan; 90(1):e0035221. PubMed ID: 34694917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pneumococcal vaccines over the last 10 years.
    Principi N; Esposito S
    Expert Opin Biol Ther; 2018 Jan; 18(1):7-17. PubMed ID: 29022363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Herbert JA; Kay EJ; Faustini SE; Richter A; Abouelhadid S; Cuccui J; Wren B; Mitchell TJ
    Vaccine; 2018 Jun; 36(26):3809-3819. PubMed ID: 29778517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
    Dagan R
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of pneumococcal vaccines.
    Wuorimaa T; Käyhty H
    Scand J Immunol; 2002 Aug; 56(2):111-29. PubMed ID: 12121432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.